|
|
|
Insider
Information: |
Aldrich Richard |
Relationship: |
Director |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
444,838 |
|
Indirect Shares
|
12,959,539 |
|
|
Direct
Value |
$1,394,222 |
|
|
Indirect Value
|
$84,759,662 |
|
|
Total
Shares |
13,404,377 |
|
|
Total
Value |
$86,153,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
81.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
2006-01-25 |
30,527 |
|
0 |
Premium* |
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2006-12-21 |
0 |
2006-12-21 |
3,662,662 |
Premium* |
|
Sequenom Inc |
SQNM |
10% Owner |
2008-06-06 |
0 |
2008-06-25 |
5,853,697 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-29 |
0 |
2008-10-29 |
1,081,410 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-10-30 |
0 |
2008-11-14 |
697,309 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2014-05-20 |
408,142 |
2014-05-20 |
299,294 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
6,169 |
2018-12-07 |
130,683 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
Director |
2015-06-08 |
0 |
2013-06-25 |
300,000 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2023-03-06 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2016-11-21 |
0 |
2017-10-12 |
934,484 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-25 |
4 |
B |
$15.77 |
$310,967 |
I/I |
19,269 |
5,872,966 |
1.5 |
- |
|
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-25 |
4 |
B |
$14.10 |
$372,680 |
I/I |
25,748 |
5,478,714 |
1.5 |
- |
|
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-25 |
4 |
B |
$15.22 |
$5,294,043 |
I/I |
341,567 |
5,853,697 |
1.5 |
- |
|
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-25 |
4 |
B |
$14.85 |
$501,626 |
I/I |
33,417 |
5,512,130 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-10-30 |
4 |
B |
$14.00 |
$14,000 |
I/I |
1,000 |
637,444 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-10-31 |
4 |
B |
$13.50 |
$144,540 |
I/I |
10,000 |
647,444 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-11-03 |
4 |
B |
$15.00 |
$13,700 |
I/I |
900 |
648,344 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-11-05 |
4 |
B |
$16.00 |
$8,000 |
I/I |
500 |
648,844 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-11-12 |
4 |
B |
$15.00 |
$154,440 |
I/I |
10,000 |
658,844 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-11-13 |
4 |
B |
$15.00 |
$403,752 |
I/I |
24,165 |
683,009 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-11-14 |
4 |
B |
$15.75 |
$235,450 |
I/I |
14,300 |
697,309 |
1.5 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2013-06-25 |
4 |
B |
$15.00 |
$11,500,005 |
I/I |
766,667 |
300,000 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2013-09-11 |
4 |
B |
$10.54 |
$51,119 |
I/I |
4,850 |
4,850 |
2.25 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2014-03-07 |
4 |
B |
$10.00 |
$1,000,000 |
I/I |
100,000 |
3,820,571 |
2.25 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2014-05-20 |
4 |
B |
$8.37 |
$8,370 |
D/D |
1,000 |
408,142 |
2.39 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2015-04-08 |
4 |
B |
$29.97 |
$74,925 |
I/I |
2,500 |
22,350 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2015-05-16 |
4 |
B |
$7.69 |
$153,800 |
I/I |
20,000 |
497,056 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-11 |
4 |
B |
$7.50 |
$995,490 |
I/I |
132,732 |
132,732 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-14 |
4 |
B |
$8.05 |
$241,602 |
I/I |
30,000 |
162,732 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-15 |
4 |
B |
$7.80 |
$237,802 |
I/I |
29,500 |
192,232 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-16 |
4 |
B |
$7.59 |
$228,302 |
I/I |
29,529 |
221,761 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-17 |
4 |
B |
$7.79 |
$232,219 |
I/I |
29,800 |
251,561 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-18 |
4 |
B |
$8.72 |
$260,743 |
I/I |
29,900 |
281,461 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-21 |
4 |
B |
$9.52 |
$310,591 |
I/I |
30,000 |
311,461 |
2.1 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2016-03-22 |
4 |
B |
$10.53 |
$313,922 |
I/I |
29,800 |
341,261 |
2.1 |
- |
|
141 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|